Coronary artery in-stent stenosis persists despite inhibition of the von Willebrand factor - collagen interaction in baboons
- 1 January 2007
- journal article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 98 (12), 1343-1349
- https://doi.org/10.1160/th07-05-0335
Abstract
Revascularization techniques, such as angioplasty and stent implantation, frequently lead to restenosis due to the formation of neointima after platelet activation and the concomittant release of various smooth muscle cell mitogenic and attractant factors. We here investigate whether inhibition of initial platelet adhesion after stent implantation can decrease neointima formation in a clinically relevant baboon model of in-stent stenosis using standard treatment with aspirin, clopidogrel and heparin. Inhibition of platelet adhesion was established by administration of the anti-von Willebrand factor (VWF) monoclonal antibody 82D6A3, which inhibits VWF binding to collagen. Administration of 82D6A3 resulted in a complete inhibition of VWF binding to collagen during the first three days after stent implantation. No thrombocytopenia or prolongation of the bleeding time was observed. Our results show that the formation of neointima was not affected in the group of baboons where primary platelet adhesion was abolished with 82D6A3 when compared to the control group. Vascular injury scores were the same in both groups. Inhibition of platelet adhesion during the first three days after stenting, on top of standard treatment with aspirin, clopidogrel and heparin, had no effect on neo-intima formation in a baboon model of in-stent stenosis. During the last decade, attempts to translate seemingly effective therapies based on smaller animal experimentation to the clinic have consistently failed. This study, using a non-human primate model that more closely resembles the clinical situation, presents a model that may be of further clinical interest for studying the prevention of restenosis. * S.F.D.M and S.S contributed equally to this manuscript.Keywords
Funding Information
- IWT (IWT020473)
This publication has 30 references indexed in Scilit:
- Paratope Determination of the Antithrombotic Antibody 82D6A3 Based on the Crystal Structure of Its Complex with the von Willebrand Factor A3-DomainPublished by Elsevier BV ,2006
- Preclinical Restenosis Models: Challenges and SuccessesToxicologic Pathology, 2006
- Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularizationJournal of the American College of Cardiology, 2004
- Reply: Long-term clopidogrel following PCI: marginal antithrombotic effects are offset by increased bleeding risksEuropean Heart Journal, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- A Consensus Tetrapeptide Selected by Phage Display Adopts the Conformation of a Dominant Discontinuous Epitope of a Monoclonal Anti-VWF Antibody That Inhibits the von Willebrand Factor-Collagen InteractionPublished by Elsevier BV ,2003
- Overexpression of a Constitutively Active Protein Kinase G Mutant Reduces Neointima Formation and In-Stent RestenosisCirculation, 2002
- Aspirin therapy for cardiovascular diseaseCurrent Opinion in Hematology, 1996
- Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine modelJournal of the American College of Cardiology, 1992
- Vessel injury, platelet adherence, and platelet survival.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1983